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Abstract
Aims: To explore the ways in which opioid-dependent parents accounted for their use of opioids
and benzodiazepines during and after pregnancy. Methods: Longitudinal qualitative interviews
[n¼ 45] with 19 opioid-dependent adults recruited in Scotland, UK, were held during the
antenatal and post-natal period. Interviews focused on parenting and parenting support within
the context of problem drug use and were analysed using a narrative informed, thematic analysis.
Findings: The majority of participants described using benzodiazepines in addition to opioids.
Almost all indicated a desire to stop or reduce opioid use, whereas cessation or reduction of
benzodiazepines was rarely prioritised. In stark contrast to opioid dependence, benzodiazepine
dependence was portrayed as unproblematic, therapeutic and acceptable in the context of
family life. Whereas opioid dependence was framed as stigmatising, benzodiazepine use and
dependence was normalised. An exception was benzodiazepine use by men which was
occasionally associated with aggression and domestic abuse. Conclusions: Drug-dependent
parents attach different meanings to opioid and benzodiazepine use and dependence in the
context of parenthood. Divergent meanings, and stigma, may impact on stated commitment to
stability or recovery from dependent drug-use. Attention should be paid to the way in which
policy and practice regarding OST and benzodiazepines reflects this divergence.
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Introduction
Parental drug misuse and its effects on children and families
are policy priorities in the UK and elsewhere (Flavin &
Paltrow, 2010; HM Government, 2010). Polydrug use is the
norm among drug users in the UK, and benzodiazepine use is
common (Bird & Robertson, 2011; Department of Health
(England), 2007; Hay, Gannon, Casey, & McKeganey, 2009;
Jones, Mogali, & Comer, 2012). Increased risks and harm,
and a range of adverse effects are associated with long-term
benzodiazepine use (Lader, 2011, 2014; O’Brien, 2005).
However, existing research on drug use and parenting has
tended to focus on opioids, opioid substitution therapy (OST),
or crack cocaine (Radcliffe, 2009, 2011; Rhodes et al., 2010),
and in the case of pregnancy, also alcohol, nicotine, marijuana
and amphetamines (Behnke & Smith, 2013). In this paper, we
examine accounts provided by polydrug-dependent parents
about their use of, and dependence on, benzodiazepines as
compared to OST.
Benzodiazepine use is highly prevalent among drug users
worldwide (Jones et al., 2012). Opioid-dependent and OST
patients use benzodiazepines to prolong and enhance the
effects of opiates (Jaffe et al., 2004), and increased rates of
dependence are associated with co-occurring psychosocial
problems (Jones et al., 2012). Weizman, Gelkopf, Melamed,
Adelson, and Bleich (2003) estimated a lifetime prevalence of
benzodiazepine dependence in the opiate-dependent popula-
tion (in or out of treatment) ranging from 61–94%.
Benzodiazepines were originally marketed in the 1960s for
the relief of anxiety, stress and insomnia (WHO, 1996) and
remain one of the most widely used psychoactive drugs
(Lader, 2011). Their use within the general population is
common, particularly among females (O’Brien, 2005). The
gendered cultural meanings of diazepam (Valium), a well-
known benzodiazepine, was cemented in the 1966 Rolling
Stones’ song ‘‘Mother’s little helper’’.
Benzodiazepines are recommended for the short-term
treatment of anxiety and insomnia (Baldwin et al., 2013).
Tolerance and withdrawal effects can develop after only a few
weeks of treatment (Lader, 2011). Adverse effects include
sedation, impaired cognitive and psychomotor functioning,
and increased likelihood of accidents and injuries (Lader,
2011; O’Brien, 2005). Withdrawal effects vary in severity and
duration, and include anxiety, insomnia, depression, impaired
memory, muscle spasms and tension, and rarely, seizures and
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psychosis (Lader, 2011). Combined benzodiazepine and
opioid use is associated with increased sedation, decreased
psychomotor performance (Lintzeris, Mitchell, Bond, Nestor,
& Strang, 2007; Lintzeris & Nielsen, 2010), poorer psycho-
social adjustment and general health, heightened risk-taking
behaviour, and increased risk of overdose (Bird & Robertson,
2011). However, evidence is limited (Jones et al., 2012), and
few studies have focused on the combined effects of opioid
and benzodiazepine dependence on pregnancy or parenting
(ACMD, 2003), despite evidence to suggest that both drugs
are problematic in these contexts.
Whilst there is evidence that parental opioid use can
compromise parenting capacity and pregnancy outcomes
(ACMD, 2003), the health and wellbeing of children and
families can also be negatively affected by social and
structural factors such as poverty, poor housing, unemploy-
ment, parental stress, domestic violence and criminal justice
involvement (Hepburn, 2004; Klee, Jackson, & Lewis, 2002).
However research indicates that despite this complexity, there
is a tendency among service users and service providers to
focus on drug use alone (Banwell & Bammer, 2006; Chandler
et al., 2013), and in most cases the primary drug of misuse
(Winklbaur et al., 2008). While this focus may relate to
concerns regarding the effects of specific drugs per se on
parenting capacity and the immediate safety of children, it
could also result in a limited view of drug dependence that
neglects to consider polydrug use and the impact of socio-
economic and structural inequalities.
While the use of opioids and OST is stigmatising,
especially in the context of pregnancy and parenthood
(Holland, Forrester, Williams, & Copello, 2013), use of
benzodiazepines in the context of mothering has historically
been characterised in a less problematic (though not entirely
positive) manner (Metzl, 2003). We found no published
literature which compared benzodiazepine and opioid
dependence, from the perspective of parents, or expectant
parents. Therefore the aim of our study was to address this gap
in the evidence and to undertake a comparative thematic
analysis of the ways in which parents accounted for their use
of opioids, OST and benzodiazepines during and after
pregnancy.
Methods
Study design and setting
This was a longitudinal, qualitative study involving 19 opioid-
dependent service users over the course of approximately one
year in order to examine changes over time in participants’
experiences with healthcare services, drug use and parenting.
Accounts were not treated as ‘‘the truth’’, but rather as a
resource through which to explore how parenting and drug
use are understood, negotiated and mutually constructed
(Bury, 2001; Rhodes, Bernays, & Houmoller, 2010). The
study was carried out in Scotland in an area with a mixed
socio-economic profile, containing areas of significant
deprivation. OST services for drug-dependent patients are
delivered via primary care and specialist community-based
substance misuse services. There are local guidelines both for
the management of substance misuse in pregnancy
(Whittaker, 2003), and parental substance use (ELBEG,
2013). Notably, a large number of patients in the area are
prescribed benzodiazepines in addition to OST.
Recruitment, sample and data collection
Participants, recruited via healthcare practitioners, were
interviewed at around 28–32 weeks gestation; 2–3 months
postnatal; and 6–9 months postnatal. Inclusion criteria were
opioid-dependence, being an expectant or recent parent, and
418 years. The sample included five fathers and fourteen
mothers, aged 23–39. All were unemployed and white,
reflecting the population of opioid-dependent adults in the
study area. Five participants were first-time parents, fourteen
other participants had between one and three children, aged
2–19. All were receiving OST at the first interview, primarily
methadone, with a minority prescribed buprenorphine or
dihydrocodeine. Eleven reported heroin use in the 12 months
prior to the first interview and thirteen reported benzodi-
azepine use during the study period.1 In five cases, diazepam
was prescribed long-term alongside OST. This reflects the
pattern of poly-drug use and prescribing practices in this
geographical setting (Bird & Robertson, 2011). In total,
45 interviews were held with nineteen participants.
Semi-structured interviews, lasting between 45–120 minutes,
addressed participants’ social background, drug use, experi-
ences with parenting, and involvement with services.
Analysis
Interviews were recorded, transcribed, anonymised and
allocated pseudonyms. NVivo 9 software was used to carry
out content coding. This was supplemented by close reading
of transcripts and thematic coding by authors AC and AW
(Ritchie, Spencer, & O’Connor, 2003). The present paper is
based on analysis of two content codes: benzodiazepine use
and methadone practice. These codes contained all interview
talk about either benzodiazepines or OST. Accounts were
compared and contrasted and analytic themes were generated
and agreed by the research team.
Ethics
The research was approved by the local NHS research ethics
committee. Participants gave informed consent and were
provided with a £20 voucher for each interview completed.
Findings
Benzodiazepine and opioid use for ‘‘normality’’ and
‘‘normal’’ life.
A common theme across parents’ accounts of all drug use was
that their substance use helped to support their attempts to
engage in ‘‘normal’’ daily life, providing a better context in
which to undertake parenting. Positive meanings were
sometimes ascribed to OST which was portrayed as enabling
parents to manage their opioid-dependence in a legal, safer
and relatively more socially acceptable manner (Chandler
1‘‘In the study period’’ refers both to reported drug use at interview, and
the 12 months prior to the first interview.
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et al., 2013). This was particularly the case for parents who
had only recently ceased use of illicit opioids:
[T]he only way to have a normal life [. . .] and keep a
normal life to normality, to being able to live again is a
methadone prescription. (Alison, 3 months postnatal)
However, parents’ accounts more often emphasised the
barriers and problems OST posed. Particularly in the post-natal
period, the structures around OST prescribing (e.g. dispensing
requirements) were highlighted as having a negative impact on
parents’ attempts to engage in a ‘‘normal’’ life or recovery-
orientated activities such as training and employment:
I’m no wanting to stay on daily supervised, especially to
try and go back to work, to go back to college. (Laura, 9
months postnatal)
This was particularly the case for those participants who
were required to have their use of OST ‘‘supervised’’ – where
methadone was consumed in the pharmacy under the surveil-
lance of the dispensing pharmacist (and any onlookers). Such
practices were framed as especially problematic for parents:
Sometimes when I see ones in the chemist wi’ their weans
[children] and I think they shouldn’t be bringing their wean
oot . . . they’re standing waiting for their meth and I try and
sit in a seat away fae them. (Melanie, antenatal)
. . . when you’re being on supervised and that, because at
the chemist I’m at, they’ve no got a bit that’s blocked off,
so you’re standing at [. . . the locality] swallowing your
methadone in the middle of the shop flair. So you get folk
looking at you [. . .] whether I’ve got [daughter] wi’ me or
no, so it’s just, ‘‘There’s the junkie, look at her’’. (Caitlin,
9 months postnatal)
Both Melanie and Caitlin’s accounts highlight the role of
stigma in shaping the experiences of parents in OST
programmes. In contrast, accounts of benzodiazepine use and
dependence tended to be framed more positively, and crucially
without reference to stigma. Most participants described using
benzodiazepines in constructive ways: treating anxiety states,
mood enhancers, providing practical and emotional support for
parenting, enabling them to engage in daily routines and
household tasks, and ultimately providing a context in which
‘‘normal’’ parenting could occur. Carol, for instance, argued
that her use of illicit diazepam was controlled, and helped her
manage household chores.
Yes, like that song, ‘‘Mother’s Little Helper’’, that’s what I
like to think of it as, just sort of gets me going, puts me in a
good mood. (Carol, 6 months postnatal)
Similar justifications for illicit use were given by two fathers
in the study. Here, Paul’s account refers to his (unsuccessful)
attempts to acquire a prescription for benzodiazepines:
I said to him [General Practitioner] I’m not taking them to
get out of my face [intoxicated]. I said I just take the two at
night to help me get to sleep. (Paul, antenatal)
Participant’s explanations for their continued use of
benzodiazepines often centred on the supposed functional
benefits of the drug in helping parent’s cope with day-to-day
life. In contrast, accounts about OST were more likely to be
framed around emphasising reduction and abstinence, narra-
tives which were largely absent when it came to benzodia-
zepines. This is most evident in the accounts of parents who
were dependent on both benzodiazepines and OST. In
Nicola’s final interview she reported that she was committed
to reducing her methadone, contrasting starkly with her
account of her benzodiazepine prescription:
I’m fed up being stuck on something, where I wake up with
my daughter, feeling like crap, and the first thing I dae is
have to swallow medicine and have a cup of tea, to feel
normal [. . .] Aye, I’m not ready for [reducing] diazepam.
That’s like mother’s little helper [. . .] they help me, to want
to get up in time to do stuff and everything. (Nicola, 10
months postnatal)
Divergent orientations towards methadone and benzodi-
azepine reduction were also discussed with Tricia. In earlier
interviews, Tricia had rejected the idea of reducing any of her
prescriptions, however, like Nicola, at 10 months postnatal
she reported reducing her methadone, but not her benzodi-
azepine dosage:
I feel like I’m still a junkie because I need this green
liquid [methadone] every day, it’s crap, but I mean I
dinnae feel like that with my Valium [. . .] Aye I need to
stay there [on the same dose of benzodiazepine] the now,
I dinnae ken [don’t know] I would get all nervous. I do
need my Valium and if they said to me they were going
to start cutting me I would panic [. . .] but they’re not,
they’re just happy at me being stable just now. (Tricia, 10
months postnatal)
Rhetoric about stability, abstinence and dependence,
therefore, were employed by participants differently accord-
ing to the particular substance they were discussing.
Accounts of substance use during pregnancy were – for
women especially – more similar. In the majority of cases,
women indicated that they wanted to reduce their dosage of
both OST and benzodiazepine. Each of these substances were
framed as problematic during pregnancy, largely centring on
potential harm to the unborn baby.
I’ve forgotten the other one, stop smoking, come off that,
like the Valium, and the methadone [. . .] and I said it
would be a bit much for me doing all of that [. . .] but it’s
no too much for me coming down from the methadone and
the Valium [. . .]. Because it’s going to be helping the baby
and me. (Iona, antenatal)
Women stressed a keen awareness that use of a range of
substances might have negative effects on their babies. Those
women dependent on multiple substances (the majority)
described a careful balance of trying to stabilise or reduce
one or more prescriptions, whilst avoiding relapse to illicit
drug use.
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Therapeutic qualities of benzodiazepine and opioid
use
A clear contrast between parents’ accounts of opioid and
benzodiazepine use and dependence was that the latter were
often framed as a legitimate method of managing anxiety,
negative emotions and past trauma. As such, while women
described reducing their benzodiazepine use during preg-
nancy, as with Nicola’s account here, once the pregnancy
ended, the need to reduce (based on perceived potential harm
to the baby) also ceased.
I’ve been on them maist of my life, and that’s to stop
paranoia, it’s to stop me going ootside, and feel like
everybody’s looking at me, and agitated, anxiety, every-
thing, so they know I’ll no’ be coming off them. I’ve
already cut doon to ten milligrams, when I was pregnant,
and nae mair, that’s it. I’ll sort the meth [OST], and then
see aboot that [diazepam] in the later future. (Nicola,
10 months post-natal)
While Nicola reported recommencing her reduction of
OST at 10 months postnatal, she maintained that she would
not be doing the same with her benzodiazepine prescription.
Carrie described regular use of illicit benzodiazepines to
manage anxiety states, and support her parenting. As with
Tricia and Nicola above, she justified her use of benzodi-
azepines, and need for a prescription of benzodiazepines, on
therapeutic grounds, whilst simultaneously affirming a desire
to reduce her methadone prescription:
I’ve been taking valium, but like the drug worker says,
instead of getting it fae the streets, ‘cos you don’t know
what’s in it, she’s going to give me a prescription [. . .] So
I’m not sitting all thingy [pulls agitated face] around the
kids and stuff. Just to calm me doon a bit, ‘cos I’m a bit,
still a bit, like anxious I think that’s the word. But I’m
down to 19ml [methadone] noo, so I’ve been coming doon
a ml a week. (Carrie, 4 months postnatal)
When participants described benzodiazepine use as thera-
peutic, their accounts framed this as reasonable, responsible
and more importantly, acceptable. Carrie emphasises that she
was seeking, and expected to be given, a prescription for
benzodiazepine, indicating that her dependence was validated
by healthcare staff. Another participant, Michael, maintained
that the illicit benzodiazepines he bought were obtained from a
reputable source and were trustworthy in terms of pharma-
ceutical content. These narratives supported participants’
arguments that their benzodiazepine use, whether illicit or
prescribed, was ‘‘controlled’’ and unproblematic. Thus, par-
ticipants constructed benzodiazepine use and dependence as a
‘‘legitimate’’ means to help them regulate problem emotional
states which might otherwise interfere with their ability to live
a ‘‘normal’’ life and effectively parent their children.
Benzodiazepines: mothers little helper; father’s ruin?
Benzodiazepine use and dependence for women was fre-
quently normalised: women described using prescribed and
illicit benzodiazepines to manage anxiety, perform household
chores or regulate sleep patterns. In contrast, while men in the
study described using benzodiazepines for similar reasons,
their accounts indicated that this was seen as problematic.
One participant framed this as explicitly related to gender:
I’ve got all these people, telling me what’s right, and
what’s wrong, and I take Valium now and again, so,
therefore, I’m not a good parent. How many bloody
mothers oot there, do you ken that take Valium? Does that
stop them from being good parents [. . .]? Where’s their
just cause [. . .]? Where’s the argument, like, because I
chose to be on Valium when I was young, he must be
f***ed up. To me, I would like to think I’m reasonably
intelligent. But, fae their angle, I’m no’, they must think
I’m a total madman, which I’m no’. (Stuart, 8 months
postnatal)
Stuart alludes to the existence of gendered stereotypes
about benzodiazepine dependence suggesting that use among
women and mothers is accepted, but that among men and
fathers is seen as dangerous or evidence of severe personality
dysfunction. While the other men in the study did not make
this gendered link explicit, the four male participants who
reported illicit use of benzodiazepines provided similar
accounts in other ways. All asserted the therapeutic benefits
of benzodiazepines, described unsuccessful attempts to
acquire prescriptions and subsequently affirmed a desire –
or need – to cease their illicit use of benzodiazepines. While it
is impossible to say based on this limited sample, these
accounts allude to the existence of gendered patterns of
prescribing, with healthcare practitioners seeming more ready
to legitimise women’s use of, and dependence on,
benzodiazepines.
Benzodiazepine use among men was also portrayed as
problematic by three women in the study who described illicit
use of benzodiazepines by their partners. One participant
suggested that her partner’s benzodiazepine use was asso-
ciated with aggression and domestic abuse, while the others
clearly indicated that benzodiazepine use for their partners
was more concerning than their use of other substances,
particularly when combined with alcohol. This parallels
findings of another study with young offenders (Forsyth,
Khan, & Mckinlay, 2011).
What I’m doing, I’m just pottering about the house quite
happy, tidying up, sorting things out, and they [benzodi-
azepines] make me feel happy, and I go to the shops and
chat away to people, and it gives me a bit more confidence,
but with him they make him angry, like I don’t know, it’s
weird. (Carol, 9 months postnatal)
In contrast, while women occasionally noted adverse
effects of benzodiazepine use, this was generally focused on
pregnancy and risks to the unborn baby. The potential harms
associated with benzodiazepine use, including the potential
for cognitive impairment and acute withdrawal symptoms,
appeared little understood or acknowledged in most partici-
pant accounts. This contrasted starkly with accounts of the
negative effects of opioid dependence.
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Discussion
This longitudinal qualitative study explored accounts of poly-
drug use within the context of pregnancy and parenting,
highlighting differential understandings and practices sur-
rounding benzodiazepine and opioid use. Our findings
illuminate a number of issues with implications for theory,
policy, prevention and education.
The accounts in our study resonate with others (Klee,
1998; Radcliffe, 2011) in demonstrating the morally difficult
nature of being a ‘‘drug-using parent’’, and the extent to
which stigma can play an important role in the day-to-day
lives of parents. Our findings suggest that while drug use, in
general, is seen as incompatible with parenting, there are clear
indications that some drugs, and types of ‘‘addiction’’, are
more ‘‘acceptable’’ than others. Crucially, our analysis
indicates important differences in the way opioid and
benzodiazepine use are understood and narrated within the
context of parenthood.
Unlike benzodiazepine use, participants in this study often
described OST in negative terms – even when they acknowl-
edged that OST was helpful in treating opioid dependence.
This dominant negative discourse on OST by drug users
themselves, has been described elsewhere (Harris &
McElrath, 2012; Lloyd, 2013; Radcliffe & Stevens, 2008),
and highlights the unique stigma attached to OST for the
treatment of opioid dependence (Keane, 2013). In contrast,
benzodiazepine use was consistently portrayed as more
socially acceptable. Participants described using benzodi-
azepines in constructive ways – to enhance social and
emotional functioning and engagement in ‘‘normal life’’ –
appealing to a ‘‘self-medicating hypothesis’’ of addiction to
explain and justify continued use (Jones, et al., 2012). These
meanings served to legitimise benzodiazepine dependence,
contrasting sharply with participants’ alignment of OST with
‘‘addict’’ or ‘‘junkie’’ identities, as documented elsewhere
(Keane, 2013; Radcliffe & Stevens, 2008).
In the context of parenthood, this was portrayed as
particularly important. Accounts of drug treatment engage-
ment and desire for abstinence, reduction or ‘‘stability’’,
differed significantly according to the type of substance being
described. Parents were more likely to describe a desire to
reduce opioid rather than benzodiazepine use, and there was
evidence that illicit benzodiazepine use was considered less
harmful than opioid use. This is noteworthy, because along-
side this complacency were occasional notes of concern,
particularly in relation to benzodiazepine use by men, and its
link with increased aggression and domestic abuse (reported
by some women participants). Accounts from this study
provide a tentative indication of the way gender may shape
understandings of benzodiazepine use. The long-term use of
benzodiazepines by mothers was framed as being therapeutic
and unproblematic. In contrast, while men reported using
benzodiazepine for similar reasons, their accounts indicated
that practitioners did not legitimise this and prescriptions
were denied.
These findings sit uneasily with the dominant ‘‘recovery’’
agenda in UK drug policy (Valentine & Treloar, 2013;
Wardle, 2012), where abstinence from all drug use is assumed
to be both desirable and necessary for ‘‘social reintegration’’.
It may be that in practice ‘‘recovery’’ refers to particular
categories of drugs, with the hierarchy of acceptability
identified among service users in this study being apparently
mirrored in prescribing practices and approaches taken to
treating addiction by clinicians (Anthierens, Habraken,
Petrovic, & Christiaens, 2007). Thus, while opioid-dependent
individuals may express a desire to reduce their opioid
prescriptions, this is not necessarily reflected in their
orientation towards other drug use, particularly benzodiazep-
ines. As such, the claim that opioid-dependent individuals
would prefer abstinence-based treatment approaches may
result from the unique stigma attached to opioids and may not
apply to all drug use, or all drugs of dependence (Lloyd, 2013;
McKeganey, Morris, Neale, & Robertson, 2004; Neale,
Nettleton, & Pickering, 2011).
Our findings suggest a need for further preventative
measures and targeted education to address benzodiazepine
use and dependence within the context of pregnancy and
parenting, especially in populations of parents engaged in
OST programmes where ‘‘stability’’ on opioids may detract
from issues associated with benzodiazepine use and depend-
ence. Reviews of benzodiazepine prescribing (Sirdifield et al.,
2013), identify a variety of reasons for inconsistent practice,
and conclude that improved education and training, provision
of non-pharmacological interventions, and enhanced commu-
nication with patients is required. Our findings support these
recommendations, especially the need for enhanced education
and training of both clinicians and patients, and extra
provision of non-pharmacological interventions to promote
the psychological and social functioning of parents on OST.
Limitations
This was an in-depth, qualitative exploration of the accounts
of nineteen drug-dependent parents on OST in a specific
geographical area. As such, our findings and conclusions
should be read as indicative and suggestive rather than
definitive. Further qualitative exploration in different geo-
graphical areas and populations is needed, as it is likely that
local or cultural contexts may shape the types of narratives
expressed in respect of the range of substances consumed.
Our findings may have limited applicability to opioid
dependent parents who are not engaged in OST programmes.
However, the contrasting accounts depicted here underline the
importance of qualitative research in illuminating under-
standings about the meanings that drugs of addiction have for
those who use them (Neale, Allen, & Coombes, 2005).
Conclusion
Although long-term benzodiazepine use and dependence
among opioid-dependent populations has been a topic of
concern for some decades (WHO, 1996) and is associated
with increased risks and harm (Lader, 2011, 2014), research
regarding the impact on pregnancy, parenting and family life
has been limited (ACMD, 2003). Our findings suggest that
parents frame benzodiazepine use and dependence as largely
unproblematic, less stigmatising and more legitimate than
OST. We suggest these divergent accounts can be under-
stood as drawing on differing cultural meanings attached to
OST and benzodiazepine use, which are reflected in policy
474 A. Chandler et al. Drugs Educ Prev Pol, 2014; 21(6): 470–475
and practice. As such, prevention, education and policy
initiatives should pay greater attention to the kind of
narratives and strategies that are employed in addressing
benzodiazepine use and dependence within opioid dependent
populations, especially in respect of the parenting and child
welfare agenda.
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